Peacey S R, Pope R M, Naik K S, Hardern R D, Page M D, Belchetz P E
Department of Endocrinology, Leeds General Infirmary, UK.
Postgrad Med J. 1993 Apr;69(810):282-4. doi: 10.1136/pgmj.69.810.282.
In patients receiving long-term therapeutic or replacement corticosteroids, delayed or inappropriate adjustment of steroid dosage during intercurrent illness may be fatal. We used a questionnaire to assess current levels of patient knowledge, awareness of the need for action during intercurrent illness and the frequency with which steroid warning cards and Medic Alert pendants were carried, in 61 patients on long-term replacement corticosteroids and in 40 patients receiving long-term therapeutic corticosteroids. Only 67 of the 101 patients taking corticosteroids were carrying a steroid warning card. Eleven of the 21 Medic Alert owners wore their pendants. Only 18 of the 41 patients in the therapeutic group and 41 of the 60 patients in the replacement group would take appropriate action during an intercurrent illness (P < 0.001). Lack of patient knowledge in this important area emphasizes the need for continuing and effective education of these groups of patients during follow-up. An information sheet detailing the exact changes to be made during intercurrent illness may help reinforce verbal advice.
在接受长期治疗性或替代性皮质类固醇治疗的患者中,在并发疾病期间延迟或不恰当地调整类固醇剂量可能是致命的。我们使用问卷调查评估了61名接受长期替代性皮质类固醇治疗的患者和40名接受长期治疗性皮质类固醇治疗的患者目前的知识水平、对并发疾病期间采取行动必要性的认识以及携带类固醇警示卡和医疗急救吊坠的频率。在101名服用皮质类固醇的患者中,只有67人携带类固醇警示卡。在21名拥有医疗急救吊坠的患者中,只有11人佩戴了吊坠。治疗组的41名患者中只有18人,替代组的60名患者中只有41人会在并发疾病期间采取适当行动(P<0.001)。患者在这一重要领域知识的欠缺强调了在随访期间对这些患者群体进行持续有效教育的必要性。一份详细说明并发疾病期间应确切做出哪些改变的信息单可能有助于强化口头建议。